<DOC>
	<DOCNO>NCT02562170</DOCNO>
	<brief_summary>Randomized control trial look early complication , cosmetic outcome , patient satisfaction thickness tissue overlie implant low pole immediate implant base breast reconstruction Skin Nipple Sparing Mastectomy either mesh ( TiLOOP Bra ) ADM ( Protexa ) . Multicenter austrian trial four breast cancer center , 50 patient randomize 1:1 TiLoop Protexa group .</brief_summary>
	<brief_title>Protexa® Versus TiLoopBra® Immediate Breast Reconstruction- A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Hereditary Breast Ovarian Cancer Syndrome</mesh_term>
	<criteria>breast cancer patient indication skin nipple spar mastectomy BRCA1/2 mutation carrier indication skin nipple spar mastectomy prior local radiotherapy inflammatory breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>breast</keyword>
	<keyword>reconstruction</keyword>
	<keyword>mesh</keyword>
	<keyword>acellular dermal matrix</keyword>
</DOC>